Novocure
UEI: P3S3GK3DTUA8
• CAGE: 81PZ6
Overview
Awardee Type
Parent
Company Description
Novocure (NASDAQ: NVCR) is an oncology company aspiring to make a difference in cancer with our novel cancer therapy Tumor Treating Fields (TTFields).
Name
Novocure
Website
Headquarters
Portsmouth, NH
United States
United States
Most Recent Award
Oct. 27, 2025
Calculating
Federal contract recipient
NOVOCURE INC
(UEI P3S3GK3DTUA8, CAGE 81PZ6)
is headquartered in Portsmouth NH.
Its primary registered NAICS is 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing.
The corporation
was founded in June 2006 and
federally registered in
December 2017.
Federal Award Analysis
Novocure federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
NOVOCURE INC
UEI
P3S3GK3DTUA8
CAGE Code
81PZ6
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
June 19, 2006
Initial Registration
Dec. 29, 2017
Last Registration
Aug. 18, 2025
Registration Activation
Aug. 18, 2025
Registration Expiration
Aug. 14, 2026
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
Manufacturer of Goods
For Profit Organization
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
1001-1500
Accepts Credit Cards
Yes